Efficacy and safety of dronedarone: A review of randomized trials

Expert Opinion on Drug Safety

Volumn 9, Issue 1, 2010, Pages 189-199

  Christiansen, Christine Benn ^a   Torp Pedersen, Christian ^a   Køber, Lars ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antiarrhythmic therapy; Atrial fibrillation; Dronedarone; Safety

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DOFETILIDE; DRONEDARONE; MULTAQ; PLACEBO; UNCLASSIFIED DRUG;

BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG EXCRETION; DRUG FATALITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DRUG WITHDRAWAL; ELDERLY CARE; EYE DISEASE; GASTROINTESTINAL SYMPTOM; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART FAILURE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; LIVER DISEASE; LIVER FUNCTION; LOADING DRUG DOSE; LUNG DISEASE; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SIDE EFFECT; SINUS RHYTHM; SKIN DISCOLORATION; THYROID DISEASE; TORSADE DES POINTES; UNSPECIFIED SIDE EFFECT;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; HEART FAILURE; HEART RATE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 74349090732     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740330903514105     Document Type: Review

References (25)

1. Kober L, Torp-Pedersen C, McMurray JJ, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008;358:2678-2687
2. Naccarelli GV, Wolbrette DL, Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: Comparative efficacy and results of trials. Am J Cardiol 2003;91:15D-26D
3. Moller M, Torp-Pedersen CT, Kober L. Dofetilide in patients with congestive heart failure and left ventricular dysfunction: Safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. Congest Heart Fail 2001;7:146-150
4. Kober L, Bloch Thomsen PE, Moller M, et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: A randomised trial. Lancet 2000;356:2052-2058
5. Pedersen HS, Elming H, Seibaek M, et al. Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving dofetilide. Am J Cardiol 2007;100:876-880
6. Brendorp B, Elming H, Jun L, et al. Qtc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide. Circulation 2001;103:1422-1427
7. Roy D, Talajic M, Dorian P, et al.; Canadian Trial of Atrial Fibrillation Investigators. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000;342:913-920
8. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833
9. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-1840.
10. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008;358:2667-2677.
11. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-1513.
12. Gautier P, Guillemare E, Marion A, et al. Electrophysiologic characterization of dronedarone in guinea pig ventricular cells. J Cardiovasc Pharmacol 2003;41:191-202
13. Chatelain P, Meysmans L, Matteazzi JR, et al. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart. Br J Pharmacol 1995;116:1949-1956
14. Zimetbaum PJ. Dronedarone for atrial fibrillation-an odyssey. N Engl J Med 2009;360:1811-1813.
15. Touboul P, Brugada J, Capucci A, et al. Dronedarone for prevention of atrial fibrillation: A dose-ranging study. Eur Heart J 2003;24:1481-1487.
16. Singh BN, Connolly SJ, Crijns HJ, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007;357:987-999.
17. Mazzini MJ, Monahan KM. Pharmacotherapy for atrial arrhythmias: Present and future. Heart Rhythm 2008;5:S26-31.
18. Tschuppert Y, Buclin T, Rothuizen LE, et al. Effect of dronedarone on renal function in healthy subjects. Br J Clin Pharmacol 2007;64:785-791
19. Davy JM, Herold M, Hoglund C, et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 2008;156:527 e1-9.
20. Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-678.
21. Connolly SJ, Crijns HJ, Torp-Pedersen C, et al. Analysis of stroke in ATHENA: A placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation 2009;120:1174-1180.
22. Barquet P. DIONYSOS Study Results Showed the Respsective Profiles of Dronedarone and Amiodarone. Press release. Available from: Http://en. sanofi-aventis.com/binaries/20081223- dionysos-fe-en-en-tcm28-23624.pdf. [Accessed 17 November 2009]
23. Piccini JP, Hasselblad V, Peterson ED, et al. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 2009;54:1089-1095.
24. Zimetbaum P, Ho KK, Olshansky B, et al. Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation. Am J Cardiol 2003;91:81-83 (Pubitemid 36050777)
25. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237